PSX
37
2
PFE
33
-8
IRM
41
10
CFG
95
2
ROK
47
4
D
41
-4
CME
45
3
MRK
63
3
LYB
22
2
DRI
66
2
SEE
52
2
AME
72
6
ALL
56
2
ZBH
42
-2
BRK.B
33
-14
AIZ
78
2
GOOG
57
2
A
43
-5
WYNN
50
2
HBAN
82
3
PSX
37
2
PFE
33
-8
IRM
41
10
CFG
95
2
ROK
47
4
D
41
-4
CME
45
3
MRK
63
3
LYB
22
2
DRI
66
2
SEE
52
2
AME
72
6
ALL
56
2
ZBH
42
-2
BRK.B
33
-14
AIZ
78
2
GOOG
57
2
A
43
-5
WYNN
50
2
HBAN
82
3
Financhill
Back

Goldman Sachs S&P 500 Premium Income ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
64

GPIX
Goldman Sachs S&P 500 Premium Income ETF

Last Price:
$52.65
Seasonality Move:
-0.32%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
64
Goldman Sachs S&P 500 Premium Income ETF (GPIX) is a Buy

Is Goldman Sachs S&P 500 Premium Income ETF a Buy, Sell or Hold?

  • The current Goldman Sachs S&P 500 Premium Income ETF [GPIX] share price is $52.66. The Score for GPIX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • GPIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPIX Stock Price Chart

What is Goldman Sachs S&P 500 Premium Income ETF's stock price today?

  • The Goldman Sachs S&P 500 Premium Income ETF share price today is $52.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPIX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

GPIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 53.94 Buy
Chaikin Money Flow: 506173 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.68 - 52.82) Buy
Bollinger Bands (100): (50.94 - 52.62) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

GPIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.49 Buy
20-day SMA: 52.45 Buy
50-day SMA: 52.31 Buy
200-day SMA: 49.65 Buy
8-day EMA: 52.43 Buy
20-day EMA: 52.41 Buy
50-day EMA: 52.21 Buy
200-day EMA: 50.57 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

Goldman Sachs S&P 500 Premium Income ETF Earnings Growth & GPIX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Goldman Sachs S&P 500 Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):